Cargando…
Moving towards personalized medicine in rheumatoid arthritis
To develop personalized medicine strategies for improvement of patient management in rheumatoid arthritis, the clinical and molecular properties of the individual patients need to be well characterized. A crucial step in this approach is to discover subgroups of patients that are characterized by a...
Autores principales: | de Jong, Tamarah D, Vosslamber, Saskia, Verweij, Cornelis L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060201/ https://www.ncbi.nlm.nih.gov/pubmed/25166016 http://dx.doi.org/10.1186/ar4565 |
Ejemplares similares
-
Type I interferon response gene expression in established rheumatoid arthritis is not associated with clinical parameters
por: de Jong, Tamarah D., et al.
Publicado: (2016) -
Effect of prednisone on type I interferon signature in rheumatoid arthritis: consequences for response prediction to rituximab
por: de Jong, Tamarah D, et al.
Publicado: (2015) -
The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients
por: Raterman, Hennie G, et al.
Publicado: (2012) -
Combining DNA-microarray data in systemic lupus erythematosus
por: Verweij, Cornelis L, et al.
Publicado: (2011) -
The type I interferon signature in leukocyte subsets from peripheral blood of patients with early arthritis: a major contribution by granulocytes
por: de Jong, Tamarah D., et al.
Publicado: (2016)